UbcH10 expression in human lymphomas

Histopathology

Volumn 54, Issue 6, 2009, Pages 731-740

  Troncone, Giancarlo ^a,b   Guerriero, Eliana ^a   Pallante, Pierloronzo ^a   Berlingieri, Maria Teresa ^a   Ferraro, Angelo ^b   Del Vecchio, Luigi ^a   Gorrese, Marisa ^a   Mariotti, Elisabetta ^a   Iaccarino, Antonino ^a   Palmieri, Emiliano A ^a   Zeppa, Pio ^a   Palombini, Lucio ^a   Fusco, Alfredo ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

Author keywords

HL; Immunohistochemistry; NHL; RT PCR; TMA; UbcH10 (E2C; Ube2c); Western blot

Indexed keywords

UBCH10 UBIQUITIN CONJUGATING ENZYME; UBIQUITIN CONJUGATING ENZYME; UNCLASSIFIED DRUG;

ARTICLE; BURKITT LYMPHOMA; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TISSUE MICROARRAY; WESTERN BLOTTING;

CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HODGKIN DISEASE; HUMANS; LYMPHOMA, NON-HODGKIN; UBIQUITIN-CONJUGATING ENZYMES;

EID: 65349141205     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2009.03296.x     Document Type: Article

References (25)

1. Sanchez-Beato M, Sanchez-Aguilera A, Piris MA. Cell cycle deregulation in B-cell lymphomas. Blood 2003 101 1220 1235. (Pubitemid 36182489)
2. Bryant RJ, Banks PM, O'Malley DP. Ki67 staining pattern as a diagnostic tool in the evaluation of lymphoproliferative disorders. Histopathology 2006 48 505 515.
3. Seng JE, Peterson BA. Indolent B-cell non-Hodgkin's lymphomas. Oncology (Williston Park) 1997 11 1883 1894, 1987; discussion 1901-2, 1. (Pubitemid 28028471)
4. Capello D, Gaidano G. Molecular pathophysiology of indolent lymphoma. Haematologica 2000 85 195 201. (Pubitemid 30366665)
5. Obermann EC, Went P, Pehrs AC et al. Cyclin B1 expression is an independent prognostic marker for poor outcome in diffuse large B-cell lymphoma. Oncol. Rep. 2005 14 1461 1467.
6. Bjorck E, Ek S, Landgren O et al. High expression of cyclin B1 predicts a favorable outcome in patients with follicular lymphoma. Blood 2005 105 2908 2915. (Pubitemid 40446285)
7. Lukas J, Bartek J. Cell division: the heart of the cycle. Nature 2004 432 564 567.
8. Rape M, Kirschner MW. Autonomous regulation of the anaphase-promoting complex couples mitosis to S-phase entry. Nature 2004 432 588 595. (Pubitemid 39626259)
9. Rape M, Reddy SK, Kirschner MW. The processivity of multiubiquitination by the APC determines the order of substrate degradation. Cell 2006 124 89 103. (Pubitemid 43069312)
10. Townsley FM, Aristarkhov A, Beck S, Hershko A, Ruderman JV. Dominant-negative cyclin-selective ubiquitin carrier protein E2-C/UbcH10 blocks cells in metaphase. Proc. Natl Acad. Sci. USA 1997 94 2362 2367. (Pubitemid 27136880)
11. Pallante P, Berlingieri MT, Troncone G et al. UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas. Br. J. Cancer 2005 93 464 471. (Pubitemid 43080022)
12. Berlingieri MT, Pallante P, Guida M et al. UbcH10 expression may be a useful tool in the prognosis of ovarian carcinomas. Oncogene 2007 26 2136 2140. (Pubitemid 46514746)
13. Berlingieri MT, Pallante P, Sboner A et al. UbcH10 is overexpressed in malignant breast carcinomas. Eur. J. Cancer 2007 43 2729 2735. (Pubitemid 350161847)
14. Wagner KW, Sapinoso LM, El-Rifai W et al. Overexpression, genomic amplification and therapeutic potential of inhibiting the UbcH10 ubiquitin conjugase in human carcinomas of diverse anatomic origin. Oncogene 2004 23 6621 6629. (Pubitemid 39265525)
15. Takahashi Y, Ishii Y, Nishida Y et al. Detection of aberrations of ubiquitin-conjugating enzyme E2C gene (UBE2C) in advanced colon cancer with liver metastases by DNA microarray and two-color FISH. Cancer Genet. Cytogenet. 2006 168 30 35. (Pubitemid 44183675)
16. Ieta K, Ojima E, Tanaka F et al. Identification of overexpressed genes in hepatocellular carcinoma, with special reference to ubiquitin-conjugating enzyme E2C gene expression. Int. J. Cancer 2007 121 33 38. (Pubitemid 46753848)
17. Washiro M, Ohtsuka M, Kimura F et al. Upregulation of topoisomerase IIalpha expression in advanced gallbladder carcinoma: a potential chemotherapeutic target. J. Cancer Res. Clin. Oncol. 2008 134 793 801.
18. LaTulippe E, Satagopan J, Smith A et al. Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. Cancer Res. 2002 62 4499 4506.
19. Lin J, Raoof DA, Wang Z et al. Expression and effect of inhibition of the ubiquitin-conjugating enzyme E2C on esophageal adenocarcinoma. Neoplasia 2006 8 1062 1071.
20. Jiang L, Huang CG, Lu YC et al. Expression of ubiquitin-conjugating enzyme E2C/UbcH10 in astrocytic tumors. Brain Res. 2008 1201 161 166. (Pubitemid 350216168)
21. Chen CC, Chang TW, Chen FM et al. Combination of multiple mRNA markers (PTTG1, Survivin, UbcH10 and TK1) in the diagnosis of Taiwanese patients with breast cancer by membrane array. Oncology 2006 70 438 446. (Pubitemid 46333765)
22. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001 25 402 408. (Pubitemid 34164012)
23. Lew DJ, Kornbluth S. Regulatory roles of cyclin dependent kinase phosphorylation in cell cycle control. Curr. Opin. Cell Biol. 1996 8 795 804. (Pubitemid 26399939)
24. Jaffe ES, Banks PM, Nathwani B, Said J, Swerdlow SH. Recommendations for the reporting of lymphoid neoplasms: a report from the Association of Directors of Anatomic and Surgical Pathology. Mod. Pathol. 2004 17 131 135. (Pubitemid 41656464)
25. Piris MA, Mollejo M, Campo E, Menarguez J, Flores T, Isaacson PG. A marginal zone pattern may be found in different varieties of non-Hodgkin's lymphoma: the morphology and immunohistology of splenic involvement by B-cell lymphomas simulating splenic marginal zone lymphoma. Histopathology 1998 33 230 239. (Pubitemid 28430512)